Viral safety issues: plasma-derived factor VIII
- 1 May 1994
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 68 (S3) , S35-S36
- https://doi.org/10.1007/bf01774528
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Inactivation of Viruses in Blood and Plasma ProductsTransfusion Medicine Reviews, 1993
- Transmission of hepatitis C with pasteurised factor VIIIThe Lancet, 1992
- Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator GroupTransfusion, 1992
- Low Risk for Hepatitis C in Hemophiliacs Given a High-Purity, Pasteurized Factor VIII ConcentrateAnnals of Internal Medicine, 1990
- Detection by PCR of hepatitis C virus in factor VIII concentratesThe Lancet, 1990
- ACUTE HEPATITIS B INFECTION AFTER TREATMENT WITH HEAT-INACTIVATED FACTOR VIII CONCENTRATEThe Lancet, 1988
- Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous TransfusionsNew England Journal of Medicine, 1987
- TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATEThe Lancet, 1985
- High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinBritish Journal of Haematology, 1985
- Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.BMJ, 1983